Department of Neuroscience and Pharmacology, Faculty of Health, University of Copenhagen, Copenhagen, Denmark.
Br J Anaesth. 2013 Apr;110(4):577-85. doi: 10.1093/bja/aes458. Epub 2012 Dec 19.
Transcranial Doppler measurements of the middle cerebral artery flow velocity are widely used as an indicator of vasospasm after aneurysmal subarachnoid haemorrhage (SAH). We investigated inter- and intraoperator agreement in SAH patients and healthy volunteers using colour-coded transcranial Doppler (TCCD), with the secondary aim of describing prediction of angiographic vasospasm and mortality.
Sixty patients and 70 healthy controls were each examined in duplicate by alternating operators. A total of 939 measurements divided on 201 examination sets were conducted by four observers. The Bland-Altman limits of agreement (LoA) were calculated using a variance components analysis. Angiography was performed on clinical indication and survival recorded at 30 days.
Differences between measurements increased with increasing average, and therefore, we analysed log-transformed values. Thus, LoA are given as ratios between measurements. There were no systematic intra- or interobserver differences (bias). The intraobserver LoA was 0.62-1.61 in patients and 0.67-1.50 in controls. However, they were 0.55-1.82 in patients with angiographic vasospasm, whereas in patients without, they were 0.66-1.52. The interobserver LoA was 0.55-1.81 in patients and 0.65-1.55 in controls, while in patients with and without angiographic vasospasm, they were 0.45-2.22 and 0.60-1.67, respectively. Flow velocity measurements day 6-10 were positively associated with 30 day mortality risk (P=0.02, logistic regression).
TCCD measurement variability is wider in patient measurements than in controls. This discrepancy can largely be explained by a higher degree of error in patients with angiographic vasospasm. Despite the considerable measurement variability in TCCD, values are predictive of outcome in SAH.
经颅多普勒测量大脑中动脉血流速度广泛用于蛛网膜下腔出血(SAH)后血管痉挛的指标。我们通过彩色经颅多普勒(TCCD)对 SAH 患者和健康志愿者进行了操作者间和操作者内的一致性研究,并描述了其对血管造影血管痉挛和死亡率的预测。
对 60 例患者和 70 例健康对照者进行了两次重复检查,检查者交替进行。由四位观察者共进行了 939 次测量,共分为 201 个检查组。采用方差分量分析计算 Bland-Altman 可重复性界限(LoA)。根据临床指征进行血管造影,记录 30 天的存活率。
随着平均水平的增加,测量值之间的差异增大,因此我们对其进行了对数转换。因此,LoA 以比值的形式给出。观察者内和观察者间均无系统的差异(偏倚)。患者的观察者内 LoA 为 0.62-1.61,对照组为 0.67-1.50。然而,血管造影显示血管痉挛的患者的 LoA 为 0.55-1.82,而无血管痉挛的患者的 LoA 为 0.66-1.52。患者的观察者间 LoA 为 0.55-1.81,对照组为 0.65-1.55,而血管造影显示血管痉挛和无血管痉挛的患者的 LoA 分别为 0.45-2.22 和 0.60-1.67。第 6-10 天的血流速度测量值与 30 天死亡率风险呈正相关(P=0.02,逻辑回归)。
TCCD 测量的变异性在患者测量中比在对照组中更大。这种差异在血管造影显示血管痉挛的患者中可以很大程度上解释为误差较高。尽管 TCCD 测量存在较大的变异性,但这些值可以预测 SAH 的预后。